ProfileGDS4459 / ENSG00000196821
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 77% 76% 77% 80% 77% 75% 80% 74% 74% 77% 74% 79% 74% 64% 78% 68% 72% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 15.7277
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.676
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 35.9677
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 45.8680
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 55.8577
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 65.6475
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 76.1980
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 85.774
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 95.7374
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.9277
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.5274
GSM623475group B, liver allograft wedge biopsie placebo treatment 26.1779
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.6274
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.9264
GSM623478group B, liver allograft wedge biopsie placebo treatment 56.178
GSM623479group B, liver allograft wedge biopsie placebo treatment 65.0968
GSM623480group B, liver allograft wedge biopsie placebo treatment 75.3272